94 related articles for article (PubMed ID: 9633852)
1. Gene therapy for ovarian carcinoma.
Robertson MW; Barnes MN; Rancourt C; Wang M; Grim J; Alvarez RD; Siegal GP; Curiel DT
Semin Oncol; 1998 Jun; 25(3):397-406. PubMed ID: 9633852
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.
Richardson A; Kaye SB
Drug Resist Updat; 2005 Oct; 8(5):311-21. PubMed ID: 16233989
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional targeting for ovarian cancer gene therapy.
Casado E; Nettelbeck DM; Gomez-Navarro J; Hemminki A; Gonzalez Baron M; Siegal GP; Barnes MN; Alvarez RD; Curiel DT
Gynecol Oncol; 2001 Aug; 82(2):229-37. PubMed ID: 11531272
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy and ovarian cancer: update of clinical trials].
Collinet P; Lanvin D; Vereecque R; Quesnel B; Querleu D
J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):532-7. PubMed ID: 11084459
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
6. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
7. [Present status and future prospects of human gene therapy].
Shimada T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():1-4. PubMed ID: 8007452
[TBL] [Abstract][Full Text] [Related]
8. [Biologic therapy and epithelial ovarian cancer].
Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
Minerva Ginecol; 2004 Feb; 56(1):91-104. PubMed ID: 14973413
[TBL] [Abstract][Full Text] [Related]
9. From gene therapy to virotherapy for ovarian cancer.
Stoff-Khalili MA; Dall P; Curiel DT
Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
[TBL] [Abstract][Full Text] [Related]
10. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and pancreatic cancer.
Clary BM; Lyerly HK
Surg Oncol Clin N Am; 1998 Jan; 7(1):217-49. PubMed ID: 9443997
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for ovarian cancer (review).
Wolf JK; Jenkins AD
Int J Oncol; 2002 Sep; 21(3):461-8. PubMed ID: 12168087
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
14. Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally.
Fewell JG; Matar MM; Rice JS; Brunhoeber E; Slobodkin G; Pence C; Worker M; Lewis DH; Anwer K
J Gene Med; 2009 Aug; 11(8):718-28. PubMed ID: 19507172
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for gastrointestinal tract cancer: a review.
Heideman DA; Gerritsen WR; Craanen ME
Scand J Gastroenterol Suppl; 2000; (232):93-100. PubMed ID: 11232500
[TBL] [Abstract][Full Text] [Related]
17. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
Pusztai L; Esteva FJ; Cristofanilli M; Hung MC; Hortobagyi GN
Cancer Treat Rev; 1999 Oct; 25(5):271-7. PubMed ID: 10544071
[TBL] [Abstract][Full Text] [Related]
18. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic agents in ovarian cancer.
Agarwal R; Linch M; Kaye SB
Eur J Surg Oncol; 2006 Oct; 32(8):875-86. PubMed ID: 16704916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
